U.S. Throat Cancer Diagnostics Market to 2032
Overview
The U.S. Throat Cancer Diagnostics Market is expected to reach a 1,224.07 USD Million by 2032 and is projected to grow at a CAGR of 11.75% from 2025 to 2032.
Revenue, 2024 (USD Million)
656.40
Forecast, 2032 (USD Million)
1,224.07
CAGR, 2024 - 2032
11.75%
Report Coverage
U.S.
U.S. Throat Cancer Diagnostics Market 2018-2032 USD Million
U.S. Throat Cancer Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 656.40 USD Million
- Projected Market Size (2032): 1,224.07 USD Million
- CAGR (2025-2032): 11.75%
Key Findings of U.S. Throat Cancer Diagnostics Market
- The U.S. Throat Cancer Diagnostics Market was valued at 656.40 USD Million in 2024.
- The U.S. Throat Cancer Diagnostics Market is likely to grow at a CAGR of 11.75% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Pharyngeal Cancer in Cancer Type Segment accounted for the largest share of the market with a revenue of 554.90 USD Million
- The fastest growing segment Stage III in Stages Segment grew Fastest with a CAGR of 14.39% during the forecast period from 2024 to 2032.
U.S. Throat Cancer Diagnostics Market Scope
U.S. Throat Cancer Diagnostics Market Segmentation & Scope
Test Type
- Others
- Biopsy
- Blood Test
- Imaging Test
Cancer Type
- Laryngeal Cancer
- Pharyngeal Cancer
Stages
- Stage 0
- Stage I
- Stage IV
- Stage II
- Stage III
Age Group
- Below 21
- 21-29
- 65 and Above
- 30-65
Product Type
- Consumables & Accessories
- Instruments
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
U.S. Throat Cancer Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 656.40 USD Million |
| Market Value in 2032 | 1,224.07 USD Million |
| CAGR (2025-2032) | 11.75% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Test Type,Cancer Type,Stages,Age Group,Product Type,End User,Distribution Channel |
Regional Insights:
-
Leading Market (2024-2032): U.S., leading in terms of revenue 656.40 USD Million in 2024
- Key Country: U.S., leading in terms of revenue with value of 656.40 USD Million in 2024.
Segments and Scope
-
U.S. Throat Cancer Diagnostics Market to 2032, By Test Type
- Imaging Test is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 300.08 USD Million in the year 2024.
- Imaging Test is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 12.83 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By Cancer Type
- Pharyngeal Cancer is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 554.90 USD Million in the year 2024.
- Pharyngeal Cancer is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 11.92 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By Stages
- Stage III is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 182.01 USD Million in the year 2024.
- Stage III is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 14.39 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By Age Group
- 30-65 is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 297.99 USD Million in the year 2024.
- 30-65 is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 12.95 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By Product Type
- Instruments is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 431.51 USD Million in the year 2024.
- Instruments is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 12.88 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 191.58 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 13.96 % in forecast period 2025-2032.
-
U.S. Throat Cancer Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in U.S. Throat Cancer Diagnostics Market to 2032 with a revenue of 446.06 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in U.S. Throat Cancer Diagnostics Market to 2032 with a Growth rate of 13.05 % in forecast period 2025-2032.
U.S. Throat Cancer Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Merck KGaA | |||
| Koninklijke Philips N.V. | |||
| Thermo Fisher Scientific Inc. | |||
| Canon Inc. | |||
| F. Hoffmann-La Roche Ltd. | |||
U.S. Throat Cancer Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
U.S. Throat Cancer Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.S. Throat Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Type,Stages,Age Group,Product Type,End User,Distribution Channel.
U.S. Throat Cancer Diagnostics Market was valued at USD 656.40(Revenue in USD Million) in 2021.
U.S. Throat Cancer Diagnostics Market is projected to grow at a CAGR of 11.75% during the forecast period of 2024 to 2032.
The Pharyngeal Cancer segment is expected to dominate the U.S. Throat Cancer Diagnostics Market, holding a largest market share of 554.90 USD Million in 2024
U.S. Throat Cancer Diagnostics Market Scope
U.S. Throat Cancer Diagnostics Market Segmentation & Scope
Test Type
- Others
- Biopsy
- Blood Test
- Imaging Test
Cancer Type
- Laryngeal Cancer
- Pharyngeal Cancer
Stages
- Stage 0
- Stage I
- Stage IV
- Stage II
- Stage III
Age Group
- Below 21
- 21-29
- 65 and Above
- 30-65
Product Type
- Consumables & Accessories
- Instruments
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Distribution Channel
- Retail Sales
- Direct Tender
Frequently Asked Questions
The U.S. Throat Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Type,Stages,Age Group,Product Type,End User,Distribution Channel.
U.S. Throat Cancer Diagnostics Market was valued at USD 656.40(Revenue in USD Million) in 2021.
U.S. Throat Cancer Diagnostics Market is projected to grow at a CAGR of 11.75% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Throat Cancer Diagnostics Market for final year is USD 1,224.07 (USD Million).
U.S. Throat Cancer Diagnostics Market Company Profiling
Frequently Asked Questions
The U.S. Throat Cancer Diagnostics Market is segmented based on Segmentation Test Type,Cancer Type,Stages,Age Group,Product Type,End User,Distribution Channel.
U.S. Throat Cancer Diagnostics Market was valued at USD 656.40(Revenue in USD Million) in 2021.
U.S. Throat Cancer Diagnostics Market is projected to grow at a CAGR of 11.75% during the forecast period of 2024 to 2032.
The estimated market value of the U.S. Throat Cancer Diagnostics Market for final year is USD 1,224.07 (USD Million).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.